bt3technologies

Reduced-intensity versus myeloablative conditioning in cord blood transplantation for AML (40-60 years) across highly mismatched HLA barriers РOn behalf of Eurocord and the Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT

The usage of myeloablative conditioning (MAC) in umbilical wire blood transplantation (UCBT) has been related to excessive non-relapse mortality (NRM) in sufferers >40 years, particularly these having a excessive HLA disparity, thus limiting wider functions. We hypothesized that the NRM benefit of decreased depth conditioning (RIC) and better GVL related to larger HLA disparities would…

Read More